Short therapy shows promise for depression in indonesia
NCT ID NCT07373080
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a brief, culturally adapted form of behavioral activation therapy, delivered by psychologists in primary care clinics, can reduce depressive symptoms in adults. 96 participants with depression will receive the therapy and be compared to usual care. The study also evaluates how well the training and supervision of psychologists works in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- brief culturally adapted behavioral activation therapy
- What this could lead to
- If successful, this could provide an effective, scalable therapy for depression in Indonesian primary care settings.
- What could go wrong
- This is a small, early-stage study (96 participants) testing feasibility and short-term effects, so results may not generalize widely or show lasting benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 96 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * aged 18-65 years old * scored 10 or above on PHQ-9 * provide informed consent Exclusion Criteria: * having diagnosis of bipolar disorder, psychotic disorders, or substance use disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depression in adults are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Puskesmas (Primary Healthcare Center)
RECRUITINGSleman, Special Region of Yogyakarta, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does blue light calm the depressed brain? a scan study investigates
- Could a new therapy boost joy in Spanish-Speakers with depression?
- Could a daily supplement boost depression therapy?
- New study tests freezing vs heating nerves to stop war wound pain
- Music as medicine: 2,000-Person trial tests playlists for mental health
- New study tests freezing vs. heating nerves to ease war wound pain